首页> 外国专利> Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections

Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections

机译:喹喔啉和蛋白酶抑制剂在组​​合物中用于治疗艾滋病和/或艾滋病毒感染的用途

摘要

Medicaments comprising, in combination, (a) one or more protease inhibitors and (b) one or more cpds. of formula (I) (or their tautomers of formula (Ia)) are new: n = 0-4; R1 = F, Cl, Br, I, CF3, CF3O, OH, 1-8C alkyl, Cya, TO, TO-R1O, TS, TSO, TSO2, NO2, NH2, N3, NHT, NT2, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, triazolyl, tetrazolyl, Ac, AcO, AcNH, CN, CONH2, COOH, TOCO, HOSO2 or SO2NH2; or Ph, PhO, PhOCO, PhS, PhSO, PhSO2, PhOSO2, PhSO2O, anilinosulphonyl, PhSO2NH, PhCO, 2-, 3- or 4-pyridyl (all opt. substd. by 5 R6); T = 1-6C alkyl; Cya = 5-8C cycloalkyl; R1 = 1-4C alkylene; R6 = F, Cl, Br, I, CN, CF3, CF3O, NO2, NH2, N3, T, Cy, TO, TS, TSO, TSO2, TNH, T2N, TOCO, Ph, PhO or 2-, 3- or 4-pyridyl; R2,R5 = H, OH, TO, ArO, AcO, CN, NH2, TNH, T2N, ArNH or AcNH; 1-8C alkyl, 2-8C alkenyl, 3-8C alkynyl, Cy, Cy', Cy-R1, Cy'-R1 or TCO (all opt. substd. by F, Cl, Br, I, CN, NH2, SH, OH, AcO, PhCOO, PhCH2O, PhO, TO, TNH, T2N, TS, TSO2, PhSO2, oxo, thioxo, carboxy or carbamoyl); 3-8C alkenyl, 2-8C alkenylcarbonyl, CyCO, Cy''CO, Cy-(1-3C alkyl)carbonyl, 5-6C cycloalkenyl- (1-3C alkyl)carbonyl, 1-8C alkenyloxycarbonyl, 2-8C alkynyloxycarbonyl, 1-8C alkylthiocarbonyl, 2-8C alkenylthiocarbonyl, 1-8C alkylaminocarbonyl, di(1-8C alkyl)aminocarbonyl, TSO2, 2-6C alkenylsulphonyl, 2-8C alkenylaminocarbonyl or di((2-6C)alkenyl)- aminocarbonyl (all opt. substd. by F, Cl, OH, RO, oxo or phenyl); 1-8C alkoxycarbonyl (opt. substd. by F, Cl, Br, OH, RO, RNH, (R)2N or RS); pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl- or 4-methylpiperazin-1-yl-carbonyl (all opt. substd. by R, 2-6C alkenyl, 1-4C acyl, oxo, thioxo, carboxy or phenyl); Ar, ArCO, ArCS, ArS-CO, ArS-CS, ArOCO, ArSO2, ArNHCO, ArNHCS, aryl(1-5C)alkylaminocarbonyl, Ar', arylalkenyl, arylalkynyl, Ar'CO, arylalkenylcarbonyl, Ar'OCO or Ar'SCO (all opt. substd. by 1-5 R6); or Het, Het', Het-alkenyl, Het'CO, Het-alkenylcarbonyl, HetOCO, HetSCO, HetNHCO, Het'OCO, Het'SCO or Het'NHCO (all opt. substd. by 1-3 R6); Ar = aryl; Ar' = aryl(1-5C)alkyl; Het = heteroaryl; Het' = heteroaryl(1-3C)alkyl; R = 1-4C alkyl; Ac' = 1-6C acyl; Ph = phenyl; Cy = 3-8C cycloalkyl; Cy' = 3-8C cycloalkenyl; Cy'' = 5-8C cycloalkenyl; R3, R4 = H; 1-8C alkyl, 2-8C alkenyl, Cy or Cy' (all opt. substd. by F, Cl, OH, NH2, SH, Ac'O, PhCOO, PhCH2O, PhO, RO, RNH, (R)2N, RS, RSO2, RSO, COOH or CONH2); Ar, aryl(1-3C)alkyl, Het or Het' (all opt. substd. by 5 R6); or R3+R4 or R3+R5 can be part of an unsatd. or satd. carbo- or heterocyclic ring of 3-8 atoms, which is opt. substd. by F, Cl, OH, NH2, T, 2-6C alkenyl, TO, 2-6C alkynyl, 1-6C acyloxy, benzoyloxy, oxo, thioxo, COOH, CONH2 or Ph); Ac' = 1-4C acyl; X = O, S, Se or NR2; with the exception of cpds. in which (a) R3 and R4 are both H, (b) R2 and R5 are H and R3 and R4 are arylalkyl, and (c) X is O and R2 and R3 are H.
机译:组合包含(a)一种或多种蛋白酶抑制剂和(b)一种或多种cpds的药物。式(I)的式(或其式(Ia)的互变异构体)是新的:n = 0-4; R 1 = F,Cl,Br,I,CF 3,CF 3 O,OH,1-8C烷基,Cya,TO,TO-R 1 O,TS,TSO,TSO 2,NO 2,NH 2,N 3,NHT, NT2,哌啶子基,吗啉代,1-吡咯烷基,4-甲基哌嗪基,硫代吗啉代,咪唑基,三唑基,四唑基,Ac,AcO,AcNH,CN,CONH2,COOH,TOCO,HOSO2或SO2NH2;或Ph,PhO,PhOCO,PhS,PhSO,PhSO 2,PhOSO 2,PhSO 2 O,苯胺磺酰基,PhSO 2 NH,PhCO,2-,3-或4-吡啶基(均被5 R 6取代);或T = 1-6C烷基; Cya = 5-8C环烷基; R 1 = 1-4C亚烷基; R 6 = F,Cl,Br,I,CN,CF3,CF3O,NO2,NH2,N3,T,Cy,TO,TS,TSO,TSO2,TNH,T2N,TOCO,Ph,PhO或2- 3-或4-吡啶基; R 2,R 5 = H,OH,TO,ArO,AcO,CN,NH 2,TNH,T 2 N,ArNH或AcNH; 1-8C烷基,2-8C烯基,3-8C炔基,Cy,Cy',Cy-R 1,Cy'-R 1或TCO(均由F,Cl,Br,I替代) ,CN,NH2,SH,OH,AcO,PhCOO,PhCH2O,PhO,TO,TNH,T2N,TS,TSO2,PhSO2,氧代,硫代,羧基或氨基甲酰基); 3-8C烯基,2-8C烯基羰基,CyCO,Cy''CO,Cy-(1-3C烷基)羰基,5-6C环烯基-(1-3C烷基)羰基,1-8C烯基氧羰基,2-8C炔基氧羰基, 1-8C烷硫基羰基,2-8C链烯基硫羰基,1-8C烷基氨基羰基,二(1-8C烷基)氨基羰基,TSO2、2-6C链烯基磺酰基,2-8C链烯基氨基羰基或二((2-6C)链烯基)-氨基羰基由F,Cl,OH,RO,氧代或苯基取代; 1-8C烷氧羰基(由F,Cl,Br,OH,RO,RNH,(R)2N或RS取代);吡咯烷-1-基,吗啉代,哌啶子基,哌嗪基或4-甲基哌嗪-1-基-羰基(均由R,2-6C烯基,1-4C酰基,氧代,硫代,羧基或苯基取代) ); Ar,ArCO,ArCS,ArS-CO,ArS-CS,ArOCO,ArSO2,ArNHCO,ArNHCS,芳基(1-5C)烷基氨基羰基,Ar',芳基烯基,芳基炔基,Ar'CO,芳基烯基羰基,Ar'OCO或Ar'SCO (全部选择用1-5 R 6代替);或Het,Het',Het-烯基,Het'CO,Het-烯基羰基,HetOCO,HetSCO,HetNHCO,Het'OCO,Het'SCO或Het'NHCO(均选择被1-3 R 6取代) ; Ar =芳基; Ar'=芳基(1-5C)烷基; Het =杂芳基; Het'=杂芳基(1-3C)烷基; R = 1-4C烷基; Ac'= 1-6C酰基; Ph =苯基; Cy = 3-8C环烷基; Cy'= 3-8C环烯基; Cy''= 5-8C环烯基; R 3,R 4 = H; 1-8C烷基,2-8C烯基,Cy或Cy'(均由F,Cl,OH,NH2,SH,Ac'O,PhCOO,PhCH2O,PhO,RO,RNH,(R)2N取代) RS,RSO2,RSO,COOH或CONH2); Ar,芳基(1-3C)烷基,Het或Het'(均由5个R 6取代);或R 3 + R 4或R 3 + R 5可以是不饱和的一部分。或坐碳数3或8的碳或杂环。取代F,Cl,OH,NH 2,T,2-6C烯基,TO,2-6C炔基,1-6C酰氧基,苯甲酰氧基,氧代,硫代,COOH,CONH2或Ph); Ac'= 1-4C酰基; X = O,S,Se或NR 2;除了cpds。其中(a)R 3和R 4均为H,(b)R 2和R 5为H且R 3和R 4为芳烷基,和(c)X为O,R 2和R 3为H。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号